H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 23,773 271 World Ranking 11701 National Ranking 1067

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Disease

His primary areas of investigation include Internal medicine, Steatohepatitis, Fatty liver, Cirrhosis and Gastroenterology. Many of his studies on Internal medicine apply to Endocrinology as well. His Steatohepatitis study is associated with Disease.

His study in Fatty liver is interdisciplinary in nature, drawing from both Proinflammatory cytokine, Steatosis and Mitochondrion. His Cirrhosis study incorporates themes from Liver disease, Metabolic syndrome, Liver transplantation and Pathology. His study looks at the relationship between Gastroenterology and topics such as Fibrosis, which overlap with Predictive value of tests.

His most cited work include:

  • Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. (1259 citations)
  • Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. (1259 citations)
  • Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. (888 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Fatty liver, Steatohepatitis and Cirrhosis. Quentin M. Anstee regularly links together related areas like Endocrinology in his Internal medicine studies. His work carried out in the field of Gastroenterology brings together such families of science as Diabetes mellitus, Body mass index, Obeticholic acid and Non invasive.

His work is dedicated to discovering how Fatty liver, Liver disease are connected with Surgery and other disciplines. His Cirrhosis research includes themes of TM6SF2, Bioinformatics and Pathology. Quentin M. Anstee works mostly in the field of Disease, limiting it down to concerns involving Obesity and, occasionally, Epidemiology.

He most often published in these fields:

  • Internal medicine (82.80%)
  • Gastroenterology (51.32%)
  • Fatty liver (51.59%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (82.80%)
  • Fatty liver (51.59%)
  • Steatohepatitis (37.83%)

In recent papers he was focusing on the following fields of study:

Quentin M. Anstee mainly focuses on Internal medicine, Fatty liver, Steatohepatitis, Gastroenterology and Fibrosis. His Liver biopsy, Non alcoholic, Nonalcoholic fatty liver disease and Liver disease study in the realm of Internal medicine interacts with subjects such as In patient. His Fatty liver research is under the purview of Disease.

His research investigates the connection between Disease and topics such as Obesity that intersect with issues in Health policy and Epidemiology. His Steatohepatitis research incorporates elements of Cancer research, Genome-wide association study, Cirrhosis, Metabolic syndrome and Type 2 Diabetes Mellitus. The concepts of his Gastroenterology study are interwoven with issues in Biopsy, Adverse effect, Obeticholic acid and Non invasive.

Between 2019 and 2021, his most popular works were:

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. (291 citations)
  • Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis (100 citations)
  • Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis (100 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

Quentin M. Anstee mainly investigates Internal medicine, Fatty liver, Steatohepatitis, Cirrhosis and Fibrosis. His work in Internal medicine addresses subjects such as Gastroenterology, which are connected to disciplines such as Adverse effect. He has included themes like Cross-sectional study and Cohort in his Fatty liver study.

His studies in Steatohepatitis integrate themes in fields like Cancer research and Immunotherapy. His work carried out in the field of Fibrosis brings together such families of science as Meta-analysis and Nonalcoholic fatty liver disease. His Disease study incorporates themes from Type 2 Diabetes Mellitus and Intensive care medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Zobair Younossi;Quentin M Anstee;Quentin M Anstee;Milena Marietti;Timothy Hardy;Timothy Hardy.
Nature Reviews Gastroenterology & Hepatology (2018)

1613 Citations

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Quentin M. Anstee;Giovanni Targher;Christopher P. Day.
Nature Reviews Gastroenterology & Hepatology (2013)

1294 Citations

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research

Quentin M. Anstee;Robert D. Goldin.
International Journal of Experimental Pathology (2006)

820 Citations

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

Stuart McPherson;Stuart McPherson;Tim Hardy;Elsbeth Henderson;Alastair D. Burt;Alastair D. Burt.
Journal of Hepatology (2015)

748 Citations

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa.
Gastroenterology (2016)

702 Citations

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Leon A Adams;Quentin M Anstee;Herbert Tilg;Giovanni Targher.
Gut (2017)

477 Citations

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

Yang-Lin Liu;Helen L Reeves;Alastair D Burt;Dina Tiniakos.
Nature Communications (2014)

452 Citations

Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

Chris Estes;Quentin M. Anstee;Maria Teresa Arias-Loste;Heike Bantel.
Journal of Hepatology (2018)

437 Citations

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee.
Journal of Hepatology (2020)

426 Citations

Cellular senescence drives age-dependent hepatic steatosis.

Mikolaj Ogrodnik;Satomi Miwa;Tamar Tchkonia;Dina Tiniakos;Dina Tiniakos.
Nature Communications (2017)

346 Citations

Editorial Boards

Journal of Hepatology
(Impact Factor: 30.083)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Quentin M. Anstee

Christopher D. Byrne

Christopher D. Byrne

National Institute for Health Research

Publications: 104

Giovanni Targher

Giovanni Targher

University of Verona

Publications: 101

Rohit Loomba

Rohit Loomba

University of California, San Diego

Publications: 98

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 95

Luca Valenti

Luca Valenti

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publications: 91

Stefano Romeo

Stefano Romeo

University of Gothenburg

Publications: 86

Arun J. Sanyal

Arun J. Sanyal

Virginia Commonwealth University

Publications: 70

Jacob George

Jacob George

University of Sydney

Publications: 67

Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Chinese University of Hong Kong

Publications: 57

Valerio Nobili

Valerio Nobili

Sapienza University of Rome

Publications: 52

Elisabetta Bugianesi

Elisabetta Bugianesi

University of Turin

Publications: 42

Naga Chalasani

Naga Chalasani

Indiana University

Publications: 40

Leon A. Adams

Leon A. Adams

University of Western Australia

Publications: 40

Atsushi Nakajima

Atsushi Nakajima

Yokohama City University

Publications: 39

Hannele Yki-Järvinen

Hannele Yki-Järvinen

University of Helsinki

Publications: 36

Kenneth Cusi

Kenneth Cusi

University of Florida

Publications: 36

Something went wrong. Please try again later.